T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIR
2151
DELISTED
CIRCOR International, Inc
CIR
| $450K | ﹤0.01% |
8,063
+763
| +10% | +$42.6K |
|
|
UCTT
2152
Ultra Clean Holdings
UCTT
$4.21B
| $448K | ﹤0.01% |
15,094
-3,805
| -20% | -$128K |
|
2153
B&G Foods
BGS
$299M
| $446K | ﹤0.01% |
45,042
+4,443
| +11% | +$55.1K |
|
2154
TG Therapeutics
TGTX
$7.34B
| $446K | ﹤0.01% |
53,339
-244,700
| -82% | -$3.41M |
|
2155
Amylyx Pharmaceuticals
AMLX
$2.5B
| $444K | ﹤0.01% |
24,220
+1,132
| +5% | +$23.9K |
|
2156
Matrix Service
MTRX
$328M
| $444K | ﹤0.01% |
37,611
-5,900
| -14% | -$44.7K |
|
|
UHT
2157
Universal Health Realty Income Trust
UHT
$573M
| $444K | ﹤0.01% |
10,969
+332
| +3% | +$15.4K |
|
|
TBCH
2158
Turtle Beach Corp
TBCH
$230M
| $444K | ﹤0.01% |
48,884
| – | – |
|
2159
Interface
TILE
$2.24B
| $443K | ﹤0.01% |
45,059
+5,047
| +13% | +$49K |
|
2160
Forrester Research
FORR
$224M
| $442K | ﹤0.01% |
15,271
+1,487
| +11% | +$45.8K |
|
2161
iShares Biotechnology ETF
IBB
$9.77B
| $442K | ﹤0.01% |
3,614
| – | – |
|
|
OPTU
2162
Optimum Communications Inc
OPTU
$228M
| $441K | ﹤0.01% |
134,657
-16,600
| -11% | -$53.6K |
|
|
BBBY
2163
Bed Bath & Beyond
BBBY
$423M
| $437K | ﹤0.01% |
30,331
+1,043
| +4% | +$25.5K |
|
|
HOUS
2164
DELISTED
Anywhere Real Estate
HOUS
| $437K | ﹤0.01% |
67,932
+2,178
| +3% | +$15.8K |
|
2165
N-able
NABL
$695M
| $437K | ﹤0.01% |
33,848
+1,618
| +5% | +$22K |
|
2166
National Healthcare
NHC
$3.44B
| $437K | ﹤0.01% |
6,815
+280
| +4% | +$17.9K |
|
2167
AdaptHealth
AHCO
$760M
| $436K | ﹤0.01% |
47,835
+8,972
| +23% | +$108K |
|
2168
SiriusPoint
SPNT
$2.7B
| $436K | ﹤0.01% |
42,826
-1,684
| -4% | -$16.9K |
|
2169
Malibu Boats
MBUU
$573M
| $435K | ﹤0.01% |
8,855
+377
| +4% | +$20.2K |
|
|
FARO
2170
DELISTED
Faro Technologies
FARO
| $434K | ﹤0.01% |
28,434
| – | – |
|
2171
iShares Core S&P Small-Cap ETF
IJR
$113B
| $433K | ﹤0.01% |
4,586
| – | – |
|
|
OSG
2172
Octave Specialty Group
OSG
$212M
| $431K | ﹤0.01% |
35,695
+1,180
| +3% | +$15.9K |
|
2173
Marten Transport
MRTN
$1.24B
| $431K | ﹤0.01% |
21,834
+1,056
| +5% | +$22.3K |
|
|
PACW
2174
DELISTED
PacWest Bancorp
PACW
| $431K | ﹤0.01% |
54,402
+5,906
| +12% | +$49.3K |
|
2175
Conduent
CNDT
$252M
| $429K | ﹤0.01% |
123,102
+20,595
| +20% | +$68.7K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.